| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 1,205 | 1,410 | 21.01. |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | DMS GROUP: EUR 50.0 MILLION IN ANNUAL REVENUE IN 2025, ORGANIC GROWTH OF +9% | 4.034 | Actusnews Wire | Dynamic growth of +17% in activity in Q4 2025, driven by sustained international development
Confirmed acceleration in growth in the 2nd half of 2025 (+14% vs. +3% in the 1st half of 2025)... ► Artikel lesen | |
| 06.01. | DMS GROUP: HALF-YEAR REPORT ON THE LIQUIDITY CONTRACT ON DECEMBER 31, 2025 | 204 | Actusnews Wire | January 6, 2026 - 5.45 pm - Diagnostic Medical Systems (Euronext Growth Paris: FR0012202497 - ALDMS), a specialist in high-performance medical imaging systems for digital radiology and bone densitometry... ► Artikel lesen | |
| 04.11.25 | DMS GROUP RECEIVES FDA CLEARANCE FOR ITS !M1 MOBILE RADIOLOGY SYSTEM AS PART OF ITS PARTNERSHIP WITH JPI HEALTHCARE SOLUTIONS IN THE UNITED STATES | 836 | Actusnews Wire | A new strategic milestone in DMS Group's expansion in North America ahead of RSNA 2025
November 4, 2025 - 5:45 pm - Diagnostic Medical Systems (Euronext Growth Paris: FR0012202497 - ALDMS), a... ► Artikel lesen | |
| DIAGNOSTIC MEDICAL SYSTEMS Aktie jetzt für 0€ handeln | |||||
| 20.10.25 | DMS GROUP: ACCELERATION OF GROWTH IN THE 3RD QUARTER 2025 | 789 | Actusnews Wire | Quarterly revenue of €11.0 million, up +10%
Dynamism in the Radiology business (+15% in Q3)
Confirmation of the objective of accelerating growth in the 2nd half of 2025 in a less dynamic... ► Artikel lesen | |
| 29.09.25 | DMS GROUP: SUSTAINED GROWTH IN HALF-YEAR RESULTS FOR 2025 | 918 | Actusnews Wire | New half-year of business growth (+3%) in the 1st half of 2025, in a demanding international environment
Strong EBITDA growth of +82% - EBITDA margin of 7.2% (vs. 4.1%)
+€1.2 million improvement... ► Artikel lesen | |
| 18.08.25 | DMS Group: An International Alliance For European Technological Sovereignty In Medical Imaging - Capital Increase Of A Total Amount Of Eur 6.9 Million Reserved For Innolux, Innocare, Bpifrance And NextStage AM | 695 | Actusnews Wire | A major international industrial alliance, supported by major institutional investors.
DMS Group, a fast-growing European industrial player, is joining forces with two listed Asian technology... ► Artikel lesen | |
| 21.07.25 | DMS GROUP: FURTHER INCREASE IN REVENUE +3% IN H1 2025 | 1.224 | Actusnews Wire | Further increase in a tense market environment and an unfavorable base effect
A 2nd half of 2025 expected to see sustained growth, driven by the implementation of the Ukraine contract and the... ► Artikel lesen | |
| 17.06.25 | STRENGTHENING OF DMS GROUP'S GOVERNANCE STRUCTURE: APPOINTMENT OF JULIEN DELPECH AS AN INDEPENDENT DIRECTOR | 464 | Actusnews Wire | June 17, 2025 - 8:00 am - Diagnostic Medical Systems (Euronext Growth Paris: FR0012202497 - ALDMS and FR001400IAQ8 - DMSBS), a specialist in high-performance medical imaging systems for digital... ► Artikel lesen | |
| 12.06.25 | DMS GROUP: INITIATION OF COVERAGE OF THE STOCK BY ODDO BHF | 513 | Actusnews Wire | June 12, 2025 - 6:00 pm - Diagnostic Medical Systems (Euronext Growth Paris: FR0012202497 - ALDMS and FR001400IAQ8 - DMSBS), a specialist in high-performance medical imaging systems for Digital... ► Artikel lesen | |
| 12.05.25 | DMS GROUP: FDA CLEARANCE FOR THE !M1 SYSTEM AND THE IMMEDIATE COMMERCIALIZATION IN THE UNITED STATES WITH MEDLINK IMAGING | 551 | Actusnews Wire | May 12, 2025 - 8:00 AM - Diagnostic Medical Systems (Euronext Growth Paris: FR0012202497 - ALDMS et FR001400IAQ8 - DMSBS), a specialist in high-performance medical imaging systems for Digital... ► Artikel lesen | |
| 07.05.25 | DMS GROUP: IMPLEMENTATION OF A LIQUIDITY CONTRACT WITH NATIXIS ODDO BHF | 494 | Actusnews Wire | May 7, 2025 - 8:00 AM - Diagnostic Medical Systems (Euronext Growth Paris: FR0012202497 - ALDMS et FR001400IAQ8 - DMSBS), a specialist in high-performance medical imaging systems for Digital Radiology... ► Artikel lesen | |
| 22.04.25 | 2025 FIRST-QUARTER REVENUE: DMS GROUP RECORDS DOUBLE-DIGIT GROWTH | 669 | Actusnews Wire | A growth dynamic that will accelerate by the end of the first half of the year, driven by the start of mobile M1 deliveries in Ukraine
€10.9 M
Turnover
10%
Increase in turnover vs. first... ► Artikel lesen | |
| 14.04.25 | DMS GROUP: DMS Group: ANNUAL RESULTS 2024 - SUSTAINED GROWTH SIGNIFICANT IMPROVEMENT OF OPERATIONAL PROFITABILITY - CONFIRMATION OF THE IMAGING 2027 PLAN | 703 | Actusnews Wire | 2024 revenue with continuous growth: €46.1 million, up 9%
Significant improvement in EBITDA: +57%
Significant reduction in operational costs and overhead costs from the 2nd half of the year
Confirmation... ► Artikel lesen | |
| 07.03.25 | DMS GROUP: DMS Group Selected by Ukrainian Authorities for the Delivery of 120 Emergency Mobile Radiology Units in a Contract Worth EUR 11M | 600 | Actusnews Wire | March 7, 2025 - 10:00 AM - Diagnostic Medical Systems (Euronext Growth Paris: FR0012202497 - ALDMS and FR001400IAQ8 - DMSBS), a specialist in high-performance medical imaging systems for Digital... ► Artikel lesen | |
| 25.02.25 | DMS GROUP PRESENTS ITS MAJOR INNOVATIONS AT THE 2025 EUROPEAN CONGRESS OF RADIOLOGY (ECR) | 580 | Actusnews Wire | 25 February 2025 - 18:00 - Diagnostic Medical Systems (Euronext Growth Paris: FR0012202497 - ALDMS et FR001400IAQ8 - DMSBS), a specialist in high-performance medical imaging systems for digital... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| CROSS COUNTRY HEALTHCARE | 7,650 | +0,66 % | Citizens maintains Cross Country Healthcare stock rating, cites discount to peer | ||
| PAVMED | 11,970 | 0,00 % | Should you chase the rally in PAVmed stock after it quadrupled on Wednesday? | ||
| SIEMENS HEALTHINEERS | 43,630 | -2,00 % | JPMORGAN stuft Siemens Healthineers auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Siemens Healthineers mit einem Kursziel von 61,30 Euro auf "Overweight" belassen. Der Konzernchef sowie der Finanzvorstand hätten... ► Artikel lesen | |
| FRESENIUS | 47,640 | +1,10 % | Fresenius: Nach 5-Jahres-Hoch - Analysten weiter optimistisch | Der Trading-Tipp des Tages ist diesmal Fresenius. In diesem Jahr läuft es für die Aktie bisher sehr gut. Gestern erreichte das Papier sogar ein 5-Jahres-Hoch. Heute findet sich Fresenius zwar am DAX-Ende... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 36,630 | +1,81 % | DAX-Check LIVE: Aixtron, BASF, Bayer, Fresenius Medical Care, K+S, SAP, Schaeffler im Fokus | Nach sieben Rekordtagen in Folge haben am Mittwoch am deutschen Aktienmarkt die Verkäufer die Oberhand gewonnen. Der DAX schloss 0,5 Prozent tiefer bei 25.286 Punkten. Nach sieben Rekordtagen in Folge... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 35,200 | -0,73 % | BERNSTEIN RESEARCH stuft CARL ZEISS MEDITEC AG auf 'Outperform' | NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat die Einstufung für Carl Zeiss Meditec vor Zahlen mit einem Kursziel von 50,55 Euro auf "Outperform" belassen. Das erste Quartal... ► Artikel lesen | |
| HEARTFLOW | 33,550 | -1,87 % | Heartflow, Inc.: Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery Disease | Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England's National Health ServiceMOUNTAIN... ► Artikel lesen | |
| ANTERIS TECHNOLOGIES GLOBAL | 6,060 | 0,00 % | Anteris Technologies Global Corp. Announces Proposed $200 Million Public Offering of Common Stock and Strategic Investment from Medtronic | MINNEAPOLIS and BRISBANE, Australia, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. ("Anteris" or the "Company") (NASDAQ: AVR, ASX: AVR), a global structural heart company committed... ► Artikel lesen | |
| GENEDX | 100,04 | +0,36 % | GeneDx to Participate in Upcoming Investor Conferences | GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences:
Stifel... ► Artikel lesen | |
| PROGYNY | 25,450 | +0,28 % | Forecasting The Future: 6 Analyst Projections For Progyny | ||
| PRIVIA HEALTH GROUP | 23,600 | +1,68 % | Privia Health Group, Inc.: Privia Health Reports Third Quarter 2025 Financial Results | Very Strong Third Quarter and Year-to-Date Performance Across the BusinessNet Income +94.1% and Adjusted EBITDA +61.6% compared to 3Q'24Implemented Providers +13.1% and Practice Collections +27.1%... ► Artikel lesen | |
| RXSIGHT | 9,950 | 0,00 % | Expert Outlook: RxSight Through The Eyes Of 5 Analysts | ||
| BRIGHTSPRING HEALTH SERVICES | 39,210 | +1,24 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P SmallCap 600 | NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 23,300 | 0,00 % | Alignment Healthcare Named to the 2026 Fortune World's Most Admired Companies List for First Time | ||
| PROCEPT BIOROBOTICS | 30,940 | +2,08 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen |